Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

IIROC Trading Resumption - VPT

Canada NewsWire March 4, 2019

IIROC Trading Halt - VPT

Canada NewsWire March 4, 2019

Ventripoint's VMS System Approved for Sale and Clinical Use in China

TheNewsWire March 4, 2019

Ventripoint to Exhibit the VMS+ 3.0 System at American College of Cardiology Annual Conference and Grant of Options

TheNewsWire February 27, 2019

Ventripoint Diagnostics Reports Progress of the Next-Generation VMS+ 3.0 System and Remote Workstation

TheNewsWire February 5, 2019

Ventripoint Announces Closing of Non-Brokered Debenture Unit Private Placement

TheNewsWire January 28, 2019

Ventripoint Awarded MDSAP Certification, the Highest Quality Standards in the Medical Device Industry

TheNewsWire January 22, 2019

Ventripoint Announces Increase in Non-Brokered Debenture Unit Private Placement

TheNewsWire January 21, 2019

Ventripoint Announces $1,000,000 Non-Brokered Debenture Unit Private Placement

TheNewsWire January 9, 2019

St. Antonius Hospital in Nieuwegein Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System

TheNewsWire January 7, 2019

Ventripoint Performs Live Demonstrations of the Next-Generation VMS+ System at EuroEcho 2018

TheNewsWire December 14, 2018

Ventripoint Announces CEO to Give Medical Keynote Presentation at Wall Street Conference in January and Engagement of Lyons Capital LLC

TheNewsWire December 13, 2018

Ventripoint to Exhibit the Next-Generation VMS+ System at EuroEcho in Milan, Italy

TheNewsWire November 29, 2018

Ventripoint Diagnostics Announces Extension of Warrants

TheNewsWire November 28, 2018

HDZ NRW Heart and Diabetes Center in Germany has Begun Using VMS+ Software for Left Ventricular Volumetric Analysis

TheNewsWire November 20, 2018

Ventripoint's Product Offering is Now Extended to Include VMS+ Software for the Analysis of 3D Echo Studies

TheNewsWire November 19, 2018

Ventripoint Has Been Approved for Government Support to Aid in the Extension of VMS Technology to Provide 4D Data

TheNewsWire November 14, 2018

St. Michael's Hospital, a Leading Cardiac Centre in Canada, Orders the Ventripoint Artificial Intelligence VMS+ Complete Heart Analysis System

TheNewsWire November 12, 2018

The University of Chicago Medical Center Cardiac Department Evaluates the VMS+ Complete Heart Analysis System

TheNewsWire November 5, 2018

Ventripoint is Now Listed on the OTCQB in the United States

TheNewsWire October 24, 2018